3-(2-aminophenyl)-1-methyl-quinoxalin-2-one

Suppliers

Names

[ CAS No. ]:
5302-27-2

[ Name ]:
3-(2-aminophenyl)-1-methyl-quinoxalin-2-one

[Synonym ]:
1,2-Diisopropyl urazole
1,2,4-Triazolidine-3,5-dione,1,2-diisopropyl
1,2-Diisopropyl-urazol
Abbott

Chemical & Physical Properties

[ Density]:
1.128g/cm3

[ Molecular Formula ]:
C8H15N3O2

[ Molecular Weight ]:
185.22400

[ Exact Mass ]:
185.11600

[ PSA ]:
59.79000

[ LogP ]:
0.49990

[ Index of Refraction ]:
1.493

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XZ5425000
CHEMICAL NAME :
1,2,4-Triazolidine-3,5-dione, 1,2-diisopropyl-
CAS REGISTRY NUMBER :
5302-27-2
BEILSTEIN REFERENCE NO. :
0882518
LAST UPDATED :
199709
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C8-H15-N3-O2
MOLECULAR WEIGHT :
185.26
WISWESSER LINE NOTATION :
T5MVNNVJ CY1&1 DY1&1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
399 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,196,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
450 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,196,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
395 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
27ZQAG "Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972 Volume(issue)/page/year: -,196,1972

Related Compounds

  • 3-[(2-aminophenyl)methyl]-1H-quinoxalin-2-one
  • 3-(2-AMINOPHENYL)-1,3-OXAZOLIDIN-2-ONE
  • 1-methyl-3-(2-oxocyclopentylidene)-4H-quinoxalin-2-one
  • 3-(2-aminophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
  • 3-[(2-aminophenyl)methylamino]-5-ethyl-6-methyl-1H-pyridin-2-one
  • 3-(4-methoxyphenyl)-2-[(1-methyl-2-oxoindol-3-ylidene)methyl]quinazolin-4-one
  • N-(4,5-dimethyl-1H-pyrazol-3-yl)-6-[(1-methylethyl)sulfonyl]-4-quinolinamine
  • N-(4,5-dimethyl-1H-pyrazol-3-yl)-6-[(tetrahydro-2H-pyran-4-yl)sulfonyl]-4-quinolinamine
  • 2,2-Dimethyl-5-({[4-(methylsulfonyl)phenyl]amino}methylidene)-1,3-dioxane-4,6-dione
  • 6-(Tert-butylsulfonyl)-4-chloro-3-iodoquinoline
  • 5-Bromo-1-hydroxy-2-pyridin-3-ylbenzimidazole
  • 5-Bromo-1-methyl-2-pyridin-3-ylbenzimidazole
  • N1-cyclopropyl-4-methoxy-benzene-1,2-diamine
  • 2,2,2-Trifluoro-1-[1-(4-propan-2-ylphenyl)triazol-4-yl]ethanone
  • 1-Piperidinecarboxylic acid, 5-(aminocarbonyl)-2-methyl-, 1,1-dimethylethyl ester, (2R,5S)-rel-
  • 5-(Pyrrolidin-1-yl)pyrimidine-2-carbonitrile
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.